Monica Vetter

Professor and Chair of Neurobiology and Anatomy

Monica Vetter

B.S. McGill University, Canada

Ph.D. University of California, San Francisco

Research

References

monica @ neuro.utah.edu

Monica Vetter's Lab Page

Monica Vetter's PubMed Literature Search

Research

My laboratory is focused on understanding the molecular pathways controlling neural development and degeneration in the vertebrate neural retina. The retina is one of the most accessible parts of the central nervous system, and is of critical importance since disorders of eye development can lead to congenital blindness, while degeneration of retinal neurons can cause progressive loss of vision at later ages.

In the developing retina we are studying how eye tissues are patterned and how retinal progenitors are directed to adopt specific retina cell fates. Our goal is to define the sequence of gene expression that governs neural differentiation in the retina, and understand how extrinsic signaling pathways modulate gene expression or function. For example, we have been investigating the mechanisms by which proneural transcription factors promote retinal neuron differentiation, and how they contribute to the ordered sequence of retinal histogenesis. We find that both the expression and activity of these factors are controlled by multiple signaling pathways, as well as through epigenetic regulation. Ultimately, the goal is to reveal general principles governing the development of neural stem cells and progenitors, which may inform efforts to harness these cells for the treatment of disease and injury of the nervous system.

To investigate the process of neurodegeneration, we are probing the mechanisms underlying glaucoma, a neurodegenerative disease of the retina that is characterized by progressive loss of retinal ganglion cells leading to blindness. Using an established mouse model for glaucoma, we have documented significant involvement of the innate immune system, and found recruitment and activation of microglia at very early stages of the disease. Microglia are the resident immune surveillance cells of the CNS, and are exquisitely sensitive to neuronal stress and injury. They have been implicated in multiple neurodegenerative diseases, although their role remains controversial. We are directly testing the role of microglia in neuronal decline, and defining the signals leading to their recruitment and activation with disease progression. Our ultimate goal is to identify key molecular pathways that can be targeted to slow or prevent blindness in glaucoma.

Vetter Figure

GFP-labeled microglia tile the surface of the retina. Confocal image of a retina whole mount preparation.

 

References

1. Green YS, Vetter ML (2011) EBF factors drive expression of multiple classes of target genes governing neuronal development. Neural Dev 6:19

2. Bosco A, Steele MR, Inman DM, Horner PJ, Vetter ML (2011) Early microglia activation in a muse model of chronic glaucoma. J Comp Neurol 519(4):599-620

3. Aldiri I, Vetter ML (2009) Characterization of the expression pattern of the PRC2 core subunit Suz12 during embryonic development of Xenopus laevis. Dev Dyn 238:3185-3192

4. Agathocleous M, Iordanova I, Willardsen MI, Xue Y, Harris WA, Vetter ML, Moore KB (2009) A directional Wnt/β-catenin-Sox2-Proneural pathway regulates the transition from proliferation to differentiation in the Xenopus retina. Development 136:3289-3299

5. Willardsen MI, Suli A, Marsh-Armstrong N, Chien C-B, Brown NL, Moore KB, Vetter ML (2009) Temporal regulation of Ath5 gene expression during Xenopus eye development. Dev Biol 326:471-481

6. Soto I, Oglesby E, Buckingham BP, Son JL, Roberson ED, Steele MR, Inman DM, Vetter ML, Horner PJ, Marsh-Armstrong N (2008) Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J Neurosci 28:548-61

7. Bosco A, Inman DM, Steele MR, Wu G, Soto I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ, Vetter ML (2008) Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci 49:1437-46

8. Hutcheson DA, Hanson MI, Moore KB, Le TT, Brown NB, Vetter ML (2005) bHLH-dependent and -independent modes of Ath5 gene regulation during retinal development. Development 132:829-839

9. Van Raay TJ, Moore KB, Iordanova I, Steele M, Jamrich M, Harris WA, Vetter ML (2005) Frizzled 5 signaling governs the neural potential of progenitors in the developing Xenopus retina. Neuron 46:23-36

Updated 7/15/2011